Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18241919rdf:typepubmed:Citationlld:pubmed
pubmed-article:18241919lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:18241919lifeskim:mentionsumls-concept:C0026764lld:lifeskim
pubmed-article:18241919lifeskim:mentionsumls-concept:C0005779lld:lifeskim
pubmed-article:18241919lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:18241919lifeskim:mentionsumls-concept:C0040808lld:lifeskim
pubmed-article:18241919lifeskim:mentionsumls-concept:C0023981lld:lifeskim
pubmed-article:18241919pubmed:issue7lld:pubmed
pubmed-article:18241919pubmed:dateCreated2008-4-21lld:pubmed
pubmed-article:18241919pubmed:abstractTextVenous thromboembolism (VTE) occurs frequently in multiple myeloma patients, especially during induction treatment with thalidomide in combination with anthracyclines and/or dexamethasone. Several coagulation abnormalities have been described in untreated myeloma patients, but these have not been prospectively evaluated during and after treatment.lld:pubmed
pubmed-article:18241919pubmed:languageenglld:pubmed
pubmed-article:18241919pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18241919pubmed:citationSubsetIMlld:pubmed
pubmed-article:18241919pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18241919pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18241919pubmed:statusMEDLINElld:pubmed
pubmed-article:18241919pubmed:monthJullld:pubmed
pubmed-article:18241919pubmed:issn0145-2126lld:pubmed
pubmed-article:18241919pubmed:authorpubmed-author:LismanTonTlld:pubmed
pubmed-article:18241919pubmed:authorpubmed-author:SonneveldPiet...lld:pubmed
pubmed-article:18241919pubmed:authorpubmed-author:LeebeekFrank...lld:pubmed
pubmed-article:18241919pubmed:authorpubmed-author:de MaatM P...lld:pubmed
pubmed-article:18241919pubmed:authorpubmed-author:LokhorstHenk...lld:pubmed
pubmed-article:18241919pubmed:authorpubmed-author:AuwerdaJohann...lld:pubmed
pubmed-article:18241919pubmed:authorpubmed-author:van...lld:pubmed
pubmed-article:18241919pubmed:issnTypePrintlld:pubmed
pubmed-article:18241919pubmed:volume32lld:pubmed
pubmed-article:18241919pubmed:ownerNLMlld:pubmed
pubmed-article:18241919pubmed:authorsCompleteYlld:pubmed
pubmed-article:18241919pubmed:pagination1078-84lld:pubmed
pubmed-article:18241919pubmed:dateRevised2008-10-3lld:pubmed
pubmed-article:18241919pubmed:meshHeadingpubmed-meshheading:18241919...lld:pubmed
pubmed-article:18241919pubmed:meshHeadingpubmed-meshheading:18241919...lld:pubmed
pubmed-article:18241919pubmed:meshHeadingpubmed-meshheading:18241919...lld:pubmed
pubmed-article:18241919pubmed:meshHeadingpubmed-meshheading:18241919...lld:pubmed
pubmed-article:18241919pubmed:meshHeadingpubmed-meshheading:18241919...lld:pubmed
pubmed-article:18241919pubmed:meshHeadingpubmed-meshheading:18241919...lld:pubmed
pubmed-article:18241919pubmed:meshHeadingpubmed-meshheading:18241919...lld:pubmed
pubmed-article:18241919pubmed:meshHeadingpubmed-meshheading:18241919...lld:pubmed
pubmed-article:18241919pubmed:meshHeadingpubmed-meshheading:18241919...lld:pubmed
pubmed-article:18241919pubmed:meshHeadingpubmed-meshheading:18241919...lld:pubmed
pubmed-article:18241919pubmed:year2008lld:pubmed
pubmed-article:18241919pubmed:articleTitleProspective evaluation of coagulopathy in multiple myeloma patients before, during and after various chemotherapeutic regimens.lld:pubmed
pubmed-article:18241919pubmed:affiliationDepartment of Hematology, University Medical Center Utrecht, The Netherlands.lld:pubmed
pubmed-article:18241919pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18241919pubmed:publicationTypeRandomized Controlled Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18241919lld:pubmed